Analysis of the First Diagnosis Symptom and Its Influencing Factors in 500 Patients with Lung Cancer

Zhongguo fei ai za zhi = Chinese journal of lung cancer
Xin ZhangJunling Li

Abstract

As the morbidity and mortality in lung cancer keep raising, we are here to discuss the effect of clinical features especially the initial symptomon on diagnosis and follow-up treatment of newly diagnosed lung cancer patients. The clinical features of the 500 patients with lung cancer in our hospital from March, 2017 to May, 2017 were analyzed retrospectively, including the initial symptom, stage, biomarkers, pathology, etc. RESULTS: There were 266 famle (53.3%), 372 adenocarcinoma (74.4%), 285 smokers (58%), status score of most patients (98.2%) was 0-1. 58.2% (n=291) of all the patients got biomarkers test, of which epidermal growth factor receptor (EGFR) mutations was 61.2%(178/291), anaplasticlymphoma kinase (ALK) fusion gene positive was 4.1% (12/291). Smoking status, initial symptom, pathological typing, TNM staging and EGFR mutation were the main factors affecting follow-up treatment. Patients with typical symptoms have shorter diagnosis time. Smoking status, lung cancer-related symptoms, pathology, TNM staging and EGFR mutation status are the main factors that affect the follow-up treatment.

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Zhonghua zhong liu za zhi [Chinese journal of oncology]
Chinese Association of OncologistsChinese Society for Clinical Cancer Chemotherapy
Zhongguo fei ai za zhi = Chinese journal of lung cancer
Xilan He, Jianhua Chen
Nihon rinsho. Japanese journal of clinical medicine
H Yamashita
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Chinese Association of Oncologists Chinese Society for Clinical Cancer Chemotherapy
© 2022 Meta ULC. All rights reserved